APTO - Aptose Biosciences Inc. (APTO) CEO Dr. William G. Rice on Q4 2021 Results - Earnings Call Transcript
Aptose Biosciences Inc. (APTO) Q4 2021 Results Conference Call March 22, 2022 05:00 PM ET Company Participants Susan Pietropaolo - Corporate Communications and IR Dr. William G. Rice - Chairman, President and CEO Dr. Joti Marango - SVP, CFO, and Chief Business Officer Dr. Rafael Bejar - SVP and Chief Medical Officer Conference Call Participants Ted Tenthoff - Piper Sandler Joe Pantginis - H.C. Wainwright Matt Biegler - Oppenheimer Soumit Roy - Jones Research Matthew Cross - Allegiance Global Partners Presentation Operator Good afternoon. My name is Jonathan, and I will be your conference operator today. I would like to welcome everyone to the Aptose Biosciences Conference Call for the Fourth Quarter Ended December 31, 2021. At this time, all participants are in a listen-only mode. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] Thank you. As a reminder, this conference call is being recorded. I
For further details see:
Aptose Biosciences Inc. (APTO) CEO Dr. William G. Rice on Q4 2021 Results - Earnings Call Transcript